« Previous
Next »
The American Journal of Medicine
Volume 122, Issue 11
, Pages 1029-1036
, November 2009
Recommendation of Low-Salt Diet and Short-term Outcomes in Heart Failure with Preserved Systolic Function
References
- Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database. J Am Coll Cardiol. 2006;47:76–84
- Outcomes in heart failure patients with preserved ejection fraction: mortality, readmission, and functional decline. J Am Coll Cardiol. 2003;41:1510–1518
- ACC/AHA clinical performance measures for adults with chronic heart failure: a report of the American College of Cardiology/American Heart Association task force on performance measures (writing committee to develop heart failure clinical performance measures) endorsed by the Heart Failure Society of America. J Am Coll Cardiol. 2005;46:1144–1178
- Early readmission of elderly patients with congestive heart failure. J Am Geriatr Soc. 1990;38:1290–1295
- . Preventable causative factors leading to hospital admission with decompensated heart failure. Heart. 1998;80:437–441
- . Effects of enalapril, tempol, and eplerenone on salt-induced hypertension in Dahl salt-sensitive rats. Clin Exp Hypertens. 2006;28:121–132
- Development of heart failure in chronic hypertensive Dahl rats: focus on heart failure with preserved ejection fraction. Hypertension. 2006;47:901–911
- . Salt intake, endothelial dysfunction, and salt-sensitive hypertension. J Clin Hypertens. 2002;4:41–46
- Responses of natriuretic peptides to acute and chronic salt loading in normotensive and hypertensive subjects. Hypertens Res. 1998;21:15–22
- . Exchangeable sodium and blood volume in normotensive and hypertensive humans on high and low sodium intake. Circulation. 1971;43:508–519
- Study on the relationship between plasma nitrite and nitrate level and salt sensitivity in human hypertension: modulation of nitric oxide synthesis by salt intake. Circulation. 2000;101:856–861
- Influence of dietary sodium on the renin-angiotensin-aldosterone system and prevalence of left ventricular hypertrophy by EKG criteria. J Hum Hypertens. 2005;19:133–138
- Early abnormalities in left ventricular diastolic function of sodium-sensitive hypertensive patients. J Hum Hypertens. 1999;13:711–716
- Improved arterial distensibility in normotensive subjects on a low salt diet. Arteriosclerosis. 1986;6:166–169
- ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult—summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. J Am Coll Cardiol. 2005;46:1116–1143
- ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)). Eur J Heart Fail. 2008;10:933–989
- Association between performance measures and clinical outcomes for patients hospitalized with heart failure. JAMA. 2007;297:61–70
- Guideline-based standardized care is associated with substantially lower mortality in Medicare patients with acute myocardial infarction: the American College of Cardiology's Guidelines Applied in Practice (GAP) projects in Michigan. J Am Coll Cardiol. 2005;46:1242–1248
- How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J. 2007;28:2539–2550
- Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model. JAMA. 2003;290:2581–2587
- “Dose-dependent” impact of recurrent cardiac events on mortality in patients with heart failure. Am J Med. 2009;122:162.e1-169.e1
- Predictors of readmission among elderly survivors of admission with heart failure. Am Heart J. 2000;139(1 Pt 1):72–77
- Congestive heart failure symptoms in patients with preserved left ventricular systolic function: analysis of the CASS registry. J Am Coll Cardiol. 1991;18:377–382
- . Estimating causal effects from large data sets using propensity scores. Ann Intern Med. 1997;127(8 Part 2):757–763
- Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med. 2006;355:251–259
- Comprehensive discharge planning with postdischarge support for older patients with congestive heart failure: a meta-analysis. JAMA. 2004;291:1358–1367
- . Discharge education improves clinical outcomes in patients with chronic heart failure. Circulation. 2005;111:179–185
- Recall of lifestyle advice in patients recently hospitalised with heart failure: a EuroHeart Failure Survey analysis. Eur J Heart Fail. 2007;9:1095–1103
- Incremental survival benefit with adherence to standardized heart failure core measures: a performance evaluation study of 2958 patients. J Card Fail. 2008;14:95–102
- Effect of discharge instructions on readmission of hospitalised patients with heart failure: do all of the Joint Commission on Accreditation of Healthcare Organizations heart failure core measures reflect better care?. Qual Saf Health Care. 2006;15:414–417
- Normal-sodium diet compared with low-sodium diet in compensated congestive heart failure: is sodium an old enemy or a new friend?. Clin Sci (Lond). 2008;114:221–230
- . Salt sensitivity of blood pressure in humans. Hypertension. 1996;27(3 Pt 2):481–490
- . Ventricular-vascular interaction in heart failure. Heart Fail Clin. 2008;4:23–36
- The pathophysiology of acute heart failure—is it all about fluid accumulation?. Am Heart J. 2008;155:9–18
Funding: Greater Flint Health Coalition, AstraZeneca Pharmaceuticals, Pfizer, Inc., GlaxoSmithKline, Blue Cross Blue Shield of Michigan Foundation (all unrestricted grants). Dr. Hummel is supported by a National Institutes of Health T-32 research training grant, 5T32HL007853-10.
Conflict of Interest: Dr. DeFranco has previously served as a consultant to AstraZeneca Pharmaceuticals and Pfizer, Inc. There are no other conflicts of interest to report.
Authorship: All authors had access to the data and contributed significantly to the final manuscript.
PII: S0002-9343(09)00598-1
doi: 10.1016/j.amjmed.2009.04.025
« Previous
Next »
The American Journal of Medicine
Volume 122, Issue 11
, Pages 1029-1036
, November 2009

